Glaxosmithkline PLC, 10% Owner at GENOCEA BIOSCIENCES, INC. (GNCA), bought 1,857,142 shares at $3.50 ($6.5M) on 2019-06-24, disclosed to the SEC on 2019-06-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |